Immix Biopharma (IMMX) Total Debt (2020 - 2022)
Immix Biopharma (IMMX) recorded Total Debt of $50,000 in Q1 2022, unchanged from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Total Debt (2020 - 2022) Analysis & Trends
- Across earlier years, Total Debt came in at $4.1 million in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,155.80 Bn | 1,124.39 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 630.65 Bn | 549.18 Bn | 17.26 Bn | 49.04 Bn |
| 3 | AbbVie | 502.74 Bn | 475.85 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 375.34 Bn | 329.72 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 301.36 Bn | 265.35 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 265.02 Bn | 238.70 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 239.16 Bn | 194.55 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 192.63 Bn | 166.82 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 171.82 Bn | 118.47 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Immix Biopharma | 543.71 Mn | 311.61 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Dec 31, 2020 | 4.10 Mn |
API Access
Immix Biopharma Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();